National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 5,957 cases where Vaccine is VARZOS and Serious and Submission Date on/before '2015-09-30'

Government Disclaimer on use of this data



Case Details

This is page 3 out of 596

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12   next


VAERS ID: 273989 (history)  
Form: Version 1.0  
Age: 83.0  
Sex: Female  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2007-03-14
Entered: 2007-03-15
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Death, Herpes zoster
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2007-02-23
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK PMH: COPD; breast cancer w/right mastectomy, nonrecurrent; hyperlipidemia; paroxysmal atrial fibrillation converted w/cardioversion; s/p throidectomy for nodule; pulmonary HTN; systemic HTN; current cigarette abuse; ETOH use; pulmonary nodule; carotid arterial disease s/p left carotid endarterectomy; mitral valve insufficiency; osteoporosis; peripheral edema; panic disorder; cellulitis of left leg; chronic back pain w/sciatica; and osteoarthritis.
Allergies:
Diagnostic Lab Data: UNK LABS from PCP: 1/31/07 ck elevated at 159; HDL elevated at 63, LDL elevated at 108, triglycerides elevated at 162. LS spine series o 12/06 revealed DDD, muscle spasm & atheroscerotic vascular dx w/prior renal artery stent placement. LABS from hospital 2/20/07: CXR revealed right pleural effusion & RLL pneumonia. WBC 18,000 w/left shift; H/H 11.9/33.1, creatinine 1.5, Na 130 EKG revealed left anterior hemiblock & complete right BBB w/degree of interventricular conduction delay. Blood, sputum & urine c/s done, results not reported.
CDC Split Type: WAES0703USA01404

Write-up: Information has been received from a physician concerning an 83 year old female who "within the last six months," in approximately 2007, was vaccinated with a dose of Zostavax. Subsequently the patient developed shingles. It was also reported that the patient was deceased from causes unrelated to the experience with Zostervax. Additional information has been requested. 3/22/07 Received Death Certificate which reveals COD as sepsis, right lower lobe pneumonia with contributing conditions of COPD & s/p right mastectomy for breast cancer. 6/8/07 Received medical records from PCP which included hospital records from 2/20-2/23/07 hospitalization after patient experienced SOB, nonproductive cough, chest pain, fever & chills, decreased appetitem malaise & weakness w/multiple falls while home. Family brought to ER & dx w/pneumonia. Admitted to ICU due to episode of hypotension & started on IV antibiotics. Respiratory status declined, developed respiratory acidosis & was intubated. Consult w/pulmonology & cardiology. Renal function then declined. Consult w/nephrology. Continued to decline, developed atrial fibrillation & arrested. Resuscitation efforts were unsuccessful & patient was pronounced. FINAL DX: Sepsis due to RLL pneumonia; respiratory failure due to sepsis & RLL pneumonia. PCP office visit of 11/15/06 notes that patient had recently received Zosavax & now had faint eruption of shingles. Tx w/Valtrex at that time. 2/2/07 office visit notes post herpes polyneuropathy tx w/cymbalta & lyrica.


VAERS ID: 275039 (history)  
Form: Version 1.0  
Age: 60.0  
Sex: Female  
Location: Colorado  
Vaccinated:2006-12-12
Onset:2006-12-28
   Days after vaccination:16
Submitted: 2007-07-11
   Days after onset:194
Entered: 2007-03-16
   Days after submission:117
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / 1 UN / SC

Administered by: Private       Purchased by: Private
Symptoms: Computerised tomogram head, Ear, nose and throat examination, Facial pain, Headache, Hypoacusis, Nervous system disorder, Scan brain, Tinnitus
SMQs:, Glaucoma (broad), Hearing impairment (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: (therapy unspecified); FIORICET TABLETS; FOSAMAX; desipramine hydrochloride; COZAAR; TOPROL XL TABLETS; niacin; MAXALT (RIZATRIPTAN BENZOATE)
Current Illness: Migraine; Hypertension; Osteopenia; Cataract; Cystitis interstitial; Neck pain
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: ears, nose, and throat 01/??/07 - see narr.; head computed axial 01/??/07 - sinuses/brain: no significant abnormalities
CDC Split Type: WAES0702USA01800

Write-up: Information has been received from a consumer concerning his 60 year old wife who on 12-DEC-2006 was vaccinated with a dose of Zostavax. On 30-DEC-2006 the patient was diagnosed with symptoms of a "typical nerve disorder". Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/14/2007; 6/22/2007; 7/5/2007. Information has been received from a reporter concerning his 60 year old caucasion wife with no drug allergies, migraine (on the right side for 40 years), hypertension, osteopenis, cataracts, and interstitial cystitis who on 12-DEC-2006 at approximately 09:00 was vaccinated SC in the left deltoid with a first dose of varicella-zoster virus vaccine live (Oka/Merck). There was no illness at the time of vaccination. Concomitant therapy included losartan potassium (MSD), TOPROL XL TABLETS, desipramine HC1, alendronate sodium (MSD), rizatriptan benzoate (MSD), niacin, FIORICHT TABLETS and "Elmira." On 30-DEC-2006, the patient was diagnosed with symptoms of a "typical nerve disorder." Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been received from the patient''s neurologist, including medical records. The neurologist noted that he was consulted only and did not get the vaccine. The patient was seen on 06-FEB-2007 by the neurologist for the chief complaint of left facial pain. The symptoms began on 28-DEC-2006. She started to notice pain around the left temple and periorbital region on the left. The pain could become very intense and have a duration of several hours. It was a constant pain most of the time with occasional sharp pains. There was no associated change in vision or speech. There was no swelling of the eye or redness and no change in the nasal drainage or congestion. She did get associated roaring tinnitus, mostly in the left ear, in association with the acute pain episodes. Her hearing was diminished during these episodes only. There may also have been some left posterior neck pain. The neck pain had been a recurrent issue for many years. She found that coughing or sneezing would exacerbate symptoms. She usually felt better when she was supine. She was treated with several courses of antibiotics without any improvement. After an ENT evaluation, it was felt that the problems were not related to the sinuses and most likely were neurologic, prompting the consult. She had CT scans of the sinuses and brain with no significant abnormalities. The impression was atypical facial pain most likely representing a variation of trigeminal cephalgia. The distribution was predominantly V1. The precise precipitating factor was not clear. Her examination was unremarkable and negative imaging with CT scan ws reassuring for no masses or other serious intracranial pathology. The plan included a trial of LYRICA and indomethacin and to be followed-up in one month. A follow-up visit was done on 23-FEB-2007. She presented with atypical facial pain and unusual form of tinnitus. Since taking the LYRICA, the pain was 90 percent controlled. However, she stated that the roaring sound in the ear persisted and was very bothersome. She was an ENT who had no specific explaination for the symptoms. He recommended a low salt diet and a diuretic. She was already using MAXIDE. Her hearing is normal. The impression was that her pain was much improved with LYRICA but persistence of roaring sensation in the head. The mechanism remained elusive as did the cause. The plan included trying cyclobenzaprine hydrochloride (MSD) 10 mgs as needed. She would continue the LYRICA 75 mg BID. The neurologist talked about looking at the cerebral vasculature with an angiogram. He was skeptical whether he would find anything treatable or even related to this. However, they might ultimately do this for completeness since a vascular malformation near the cochlea might produce a phenomenon like this. She would follow-up in one month. She was seen for a follow-up visit on 19-APR-2007. Her tinnitus had almost fully resolved. Her facial pain was well controlled. There were still intermittent pains, particularly with any form of valsalva such as coughing, laughing or sneezing. The impression was stable atypical facial pain but concerns about valsalva maneuvers including symptoms. The possibility of aneurysm or vascular anomaly was discussed. The plan included recommending a CT angiogram of the head but he would not expect it to show any abnormality. The patient would decide if she wanted to proceed with the test. The patient''s experience was considered to be disabling by the neurologist. No further information is expected. This is an amended report. The reporter was changed from a consumer to the neurologist. Follow up information was received from a physician who reported that the patient developed pain around the left eye and roaring in the ear, especially with valsalva, that was diagnosed as temporal mandibula myofascial syndrome. The patient had a CT of the brain and sinuses and visist with an ENT and a neurologist. The physician noted that the patient got ZOSTAVAX on 12-DEC-2006 and the adverse events started later in December 2006. The patient''s experience was considered to be disabling by the neurologist. No further information is expected.


VAERS ID: 274368 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2007-03-19
Entered: 2007-03-20
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Condition aggravated, Herpes zoster
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Immune system disorder
Preexisting Conditions: Shingles
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0703USA01372

Write-up: Information has been received from a medical assistant (also reported as a registered nurse) concerning an immunocompromised female with a history of shingles who on an unspecified date was vaccinated with one dose of Zostavax. Subsequently the patient developed a "serious case of shingles and was hospitalized." The patient was reported to be hospitalized in another country and therefore the length of hospitalization was not known at the time of the report. It was reported that the patient attended the oncology clinic where the medical assistant worked, though the prescribing physician did not work in the clinic. The reason the patient attended the oncology clinic was not provided. There was no product quality complaint involved. No further information was provided. The patient;s shingled were considered serious for hospitalization. Additional information has been requested.


VAERS ID: 274415 (history)  
Form: Version 1.0  
Age: 65.0  
Sex: Female  
Location: Colorado  
Vaccinated:2006-11-03
Onset:2006-11-22
   Days after vaccination:19
Submitted: 2007-03-20
   Days after onset:117
Entered: 2007-03-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 LA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Herpes zoster
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Allegra daily, Nexium 40 mg daily, Omacor 1g daily, Paxil 10 mg daily, Valium prn
Current Illness: none
Preexisting Conditions: Conditions: Anemia, Diverticulosis, Gastritis, h/o Hep B, hyperlipidemia, menopause, h/o PE, TIA, positive PPD, urticaria (chronic) Allergies: Cephalosporins, Levaquin, Doxycycline, Sulfa, Tetracycline, Niacin HX of gastritis, costochondritis, intermittent chronic noncardiac chest pain, positive PPD.
Allergies:
Diagnostic Lab Data: n/a
CDC Split Type:

Write-up: Patient developed actual shingles approximately 2 weeks after receiving the vaccine 04/04/07-records received from facility for DOS 11/22-11/23/06 DC DX: chest pain syndrome status post coronary angiography which revealed normal coronary anatomy on 11/22/06-HX of pulmonary embolism 2002. Hyperlipidemia. Depression/anxiety. Chronic urticaria. Asthma. Records do not mention shingles. 04/10/07-records received from PCP-note for DOS 11/29/06-rash on left shoulder reddish evidence of healing vesicles.


VAERS ID: 274816 (history)  
Form: Version 1.0  
Age: 79.0  
Sex: Female  
Location: Florida  
Vaccinated:2007-03-07
Onset:2007-03-20
   Days after vaccination:13
Submitted: 2007-03-26
   Days after onset:6
Entered: 2007-03-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. UNKNOWN / UNK - / -

Administered by: Unknown       Purchased by: Unknown
Symptoms: Idiopathic thrombocytopenic purpura, Mouth haemorrhage, Mouth ulceration, Purpura, Rectal haemorrhage
SMQs:, Severe cutaneous adverse reactions (broad), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Gastrointestinal haemorrhage (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Ischaemic colitis (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 11 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: RECENT LEVAQUIN PO
Current Illness: UNKNOWN
Preexisting Conditions: ALLERGIES: LATEX, PCN. PMH: HTN, BLADDER CANCER (NO RECENT TX) records received 7/26/07-History of bladder cancer. Borderline hypertension.
Allergies:
Diagnostic Lab Data: records received 7/26/07-CT head:no evidence of acute intracranial lesion. Right sphenoid air cell inflammatory disease. Initial platelet count 8.
CDC Split Type:

Write-up: ITP (PLATELET COUNT 8000 ON ADMISSION), MULTIPLE ORAL ULCERATIONS/BLEEDING, PUPURIC SPOTS ON ARMS AND LEGS, RECTAL BLEEDING. 7/26/07-records received.for DOS 03/24-04/04/07-DC DX: Idiopathic thrombocytopenia. Hemolytic anemia. Admitted with sore throat and bleeding for a day. Known to have extensive oropharyngeal petechiae and extensive bleeding in extremities. Treated with IV gamma globulin and changed to steroids. Developed hemolytic anemia. Week prior to hospitalization, upper respiratory symptoms, self administered Levaquin. Noticed progressive hemorrhagic blisters throughout mouth. Ulcers started day she started taking Levaquin.


VAERS ID: 275115 (history)  
Form: Version 1.0  
Age: 73.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2007-01-10
Onset:2007-02-01
   Days after vaccination:22
Submitted: 2007-03-28
   Days after onset:54
Entered: 2007-03-29
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0623F / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Blood sodium decreased, Ear pain, Facial pain, Herpes zoster, Pain, Rash
SMQs:, Anaphylactic reaction (broad), Hyponatraemia/SIADH (narrow), Glaucoma (broad), Chronic kidney disease (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: (therapy unspecified) antimicrobial (unspecified)
Current Illness:
Preexisting Conditions: General symptom; Pneumonia
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0703USA03688

Write-up: Information has been received from a 73 year old female consumer with a history of "several health conditions" and pneumonia in December 2006, who on 10-JAN-2007 was vaccinated with one dose of Zostavax. Concomitant therapy included an antibiotic to treat the pneumonia along with several other unknown medications. On 13-MAR-2007 the patient developed a "shingles related rash." She stated that the rash began on the back of her neck as a bumpy rash and spread to her collar bone area, arm, shoulder, chest and she felt a shooting pain on the side of her face and a painful ear ache. Medical attention was sought, the physician prescribed VALTREX 1 gm for 7 days to treat the shingles rash. At the time of the report the patient had not recovered. There was no product quality complaint involved. No further information was provided. Information received on 19-MAR-2007 contained the following adverse experience: hospitalization for low sodium levels (February 2007) "related to another medical condition that she has." The length of hospitalization was not provided. Additional information has been requested.


VAERS ID: 275633 (history)  
Form: Version 1.0  
Age: 76.0  
Sex: Male  
Location: California  
Vaccinated:2007-03-02
Onset:2007-03-02
   Days after vaccination:0
Submitted: 2007-04-04
   Days after onset:32
Entered: 2007-04-05
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0621F / 1 LA / SC

Administered by: Private       Purchased by: Other
Symptoms: Arachnoid cyst, Blood test normal, CSF glucose, CSF lymphocyte count, CSF mononuclear cell count increased, CSF test abnormal, CSF white blood cell count, Disorientation, Encephalitis viral, Eosinophil count, Headache, Herpes simplex serology negative, Impaired driving ability, Lumbar puncture, Meningitis viral, Metabolic function test normal, Neck pain, Nuclear magnetic resonance imaging brain normal, Pain, Viral test negative, White blood cell count
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Arthritis (broad), Hypoglycaemia (broad), Dehydration (broad), Opportunistic infections (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: magnetic resonance 03/05?/07 - brain - no acute infarct. No evid encephalitis or meningitis/ 13 cm cystic lesion - sm. arachoid cyst, blood chemistry 03/05?/07 - normal, eosinophil count 03/05?/07 5%, lymphocyte count 03/05?/07 17%, monocyte count 03/05?/07 8.4%, neutrophil count 03/05?/07 68%, WBC count 03/05?/07 10.80, CSF HSV Ab 03/05?/07 - PCR - negative, CSF glucose 03/05?/07 68, cerebrospinal fluid 80 mg/d, CSF white cell count 03/05?/07 - 23 mcL 100 % mononuclear Records received 4/24/07-MRA of brain no acute infarct no evidence of encephalitis or meningitis. CSF protein 81, glucose 68, WBC 23 100% mononuclear. PCR for herpes zoster. PCR for herpes simplex negative.
CDC Split Type: WAES0703USA05480

Write-up: Information has been received from a physician concerning a 75 year old male with no known history who on 02-MAR-2007 was vaccinated SC in the left deltoid with a 0.65 ml first dose of Zostavax (lot # 652925/0621F). There was no concomitant medication or illness at the time of vaccination. Two hours after vaccination on 02-MAR-2007, the patient started developing pain in his neck as well as some achiness. He developed some disorientation and erratic driving over the weekend and was seen by the physician on 05-MAR-2007. The physician recommended work-up for possible Zostavax related meningoencephalitis or viral encephalitis. He was admitted to the hospital observation unit and under went neurological consultation. A MRA of the brain showed no acute infarct, no MRA evidence of encephalitis or meningitis. A 13 mm right medical posterior inferior cerebellar cystic lesion represents a small arachnoid cyst versus the etiology of doubtful clinical significance. He underwent a spinal tap under fluoroscopic guidance which revealed the following findings: fluid protein 80 mg/dl, glucose 68 and white blood count was 23 white cells per microliter, 100% of mononuclear. The patient had PCR for herpes simples virus which was negative. The patient''s basic metabolic panel was normal and his white count was 10,800 with 68% neutrophils, 17% lymphocytes, 8.4% monocytes and 5% eosinophils. The patient was discharged to home on 08-MAR-2007. His mental status did not change and he still had the same symptomatology of some disorientation and loss of higher cortical function. The discharge diagnosis was viral meningitis of undetermined etiology possibly post vaccination with Zostavax. The patient''s discharge medications included PROTONIX "quarter" mg QD, naprosyn 300 mg PO BID and MIDRIN one capsule PO q 6h for severe headaches. The plan was for the patient to follow-up as an outpatient. As of 30-MAR-2007 the patient was at home and "doing much better". A lot check has been requested. It was reported that CSF fluid was available for PCR testing and the patient was enrolled in the Varicella Zoster virus identification program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the manufacturer vaccine VZV strain. The patient''s viral meningitis was considered to be immediately life-threatening. Additional information has been requested. 04/24/07-records received from facility for DOS 03/05-03/08/07-DC DX: viral meningitis of undetermined etiology possible post vaccination with Zostavax. 3/2/07-Two hours after receiving vaccine C/O pain in neck as well as some achiness, developed disorientation and erratic driving.


VAERS ID: 276532 (history)  
Form: Version 1.0  
Age: 76.0  
Sex: Female  
Location: New York  
Vaccinated:2007-03-22
Onset:2007-03-30
   Days after vaccination:8
Submitted: 2007-04-16
   Days after onset:17
Entered: 2007-04-17
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0162U / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Herpes zoster, Varicella post vaccine
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0704USA00331

Write-up: Information has been received from a healthcare worker concerning a 76 year old female who on 22-MAR-2007 was vaccinated with a dose of Zostavax (lot # 656394/0162U). On 30-MAR-2007 the patient experienced shingles on her back. Unspecified medical attention was sought. At the time of the report the patient had not recovered. There was no product quality complaint involved. No further information was available. The patient''s shingles were considered disabling. Additional information has been requested.


VAERS ID: 276533 (history)  
Form: Version 1.0  
Age: 39.0  
Sex: Female  
Location: Unknown  
Vaccinated:2007-03-29
Onset:2007-03-29
   Days after vaccination:0
Submitted: 2007-04-16
   Days after onset:18
Entered: 2007-04-17
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Diabetes mellitus inadequate control, Drug exposure during pregnancy, Inappropriate schedule of drug administration, Pregnancy test positive
SMQs:, Hyperglycaemia/new onset diabetes mellitus (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Normal pregnancy conditions and outcomes (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: BYETTA, NOVOLOG, LANTUS, PRINIVIL
Current Illness: Pregnancy NOS (LMP = Unknown), Type II diabetes mellitus; Blood sugar abnormal; Obesity
Preexisting Conditions: Shingles
Allergies:
Diagnostic Lab Data: Beta-human chorionic 04/05/07, positive;
CDC Split Type: WAES0704USA01007

Write-up: Information has been received from a nurse practitioner concerning a 39 year old female with no known allergies, type 2 diabetes mellitus, uncontrolled blood sugars and obesity and a history of shingles 2 or 3 times who on 29-MAR-2007, at her request, was vaccinated IM with a 0.65 "mg" dose of Zostavax. Concomitant therapy included LANTUS, NOVOLOG, BYETTA and lisinopril (manufacturer unknown). On 05-APR-2007 the patient had a positive pregnancy test. It was reported that the patient has had uncontrolled blood sugars "for the past few months" with sugars to 366. The "past few days" (since approximately 01-APR-2007) her blood sugars had been in the 180''s. On 05-APR-2007 she was hospitalized for stabilization and monitoring of her blood sugars with pregnancy. At the time of the report the patient had not recovered. There was no product quality complaint involved. No further information was available. The patient''s events were considered serious for hospitalization. The reporter considered the patient''s uncontrolled blood sugars to be an other important medical event. Additional information has been requested.


VAERS ID: 277353 (history)  
Form: Version 1.0  
Age:   
Sex: Male  
Location: Georgia  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2007-04-24
Entered: 2007-04-25
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / SC

Administered by: Other       Purchased by: Other
Symptoms: Blood calcium increased, Renal failure
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0704USA02431

Write-up: Information has been received from a physician concerning a male with no pertinent medical history who was vaccinated SC with a dose of Zostavax. Subsequently three days after vaccination the patient experienced renal failure and high calcium and was hospitalized for five days. No additional information was provided. There was no product quality complaint involved. Additional information has been requested.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=3&VAX=VARZOS&SERIOUS=ON&SUB_YEAR_HIGH=2015&SUB_MONTH_HIGH=09


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166